Celadon Pharmaceuticals (LON:CEL) Trading 1.8% Higher – Time to Buy?

Celadon Pharmaceuticals Plc (LON:CEL) shares were up 1.8% during mid-day trading on Friday . The company traded as high as GBX 30 ($0.38) and last traded at GBX 28 ($0.35). Approximately 7,615 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 77,203 shares. The stock had previously closed at GBX 27.50 ($0.35).

Celadon Pharmaceuticals Price Performance

The stock has a market capitalization of £19.28 million, a P/E ratio of -350.00 and a beta of -0.26. The company has a debt-to-equity ratio of 194.82, a quick ratio of 6.97 and a current ratio of 1.92. The firm has a 50-day moving average price of GBX 31.53 and a 200 day moving average price of GBX 55.99.

Celadon Pharmaceuticals Company Profile

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.